Brainsway (BRSYF) FCF Margin (2018 - 2026)
Brainsway's (BRSYF) quarterly FCF Margin came in at 42.04% in Q2 2026, down 6842.0% on a YoY basis from 0.62% in Q2 2025, and up 236.52% quarter-over-quarter from 12.49% in Q1 2026.
Powered by 
Analysis
Brainsway (BRSYF) FCF Margin (2018 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported FCF Margin for 9 consecutive years, with 42.04% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 6842.0% year-over-year to 42.04%; the trailing twelve-month figure through Jun 2026 stood at 15.32% (down 4544.0% YoY), and the FY2025 full-year result was 36.83%, up 247.0% from the prior year.
- FCF Margin rose to 42.04% in Q2 2026 per BRSYF's latest filing, from 12.49% in the prior quarter.
- Across five years, FCF Margin topped out at 110.46% in Q2 2025 and bottomed at 53.45% in Q1 2023.
- Historically, FCF Margin has averaged 13.56% across 5 years, with a median of 22.23% in 2023.
- The sharpest annual moves came in 2022 and 2024: FCF Margin plunged 9326 bps in 2022, then surged 9635 bps in 2024.
- Over 5 years, FCF Margin stood at 37.18% in 2022, then jumped by 187 bps to 32.3% in 2023, then advanced by 20 bps to 38.7% in 2024, then plunged by 136 bps to 13.89% in 2025, then jumped by 403 bps to 42.04% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 42.04%, 12.49%, and 13.89% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.73% |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 42.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.04% |
| Mar 31, 2026 | 12.49% |
| Dec 31, 2025 | -13.89% |
| Sep 30, 2025 | 16.18% |
| Jun 30, 2025 | 110.46% |
| Mar 31, 2025 | 52.47% |
| Dec 31, 2024 | 38.70% |
| Sep 30, 2024 | 34.07% |
| Jun 30, 2024 | 21.94% |
| Mar 31, 2024 | 42.90% |
| Dec 31, 2023 | 32.30% |
| Sep 30, 2023 | 22.52% |
| Jun 30, 2023 | 31.83% |
| Mar 31, 2023 | -53.45% |
| Dec 31, 2022 | -37.18% |
| Sep 30, 2022 | -43.01% |
| Jun 30, 2022 | -28.80% |
| Mar 31, 2022 | -37.48% |
| Dec 31, 2021 | 56.08% |
| Sep 30, 2021 | -5.09% |